Repaglinide versus sulfonylurea in combination with bedtime NPH insulin in patients with type 2 diabetes with secondary failure to oral treatment

被引：0
|
作者：
Strojek, K
Polaszewska-Muszynska, M
Krassowski, J
Gumprecht, J
Rudzki, H
Olejniczak, H
Nazar, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A135 / A135
页数：1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes
    Min, Jea Young
    Griffin, Marie R.
    Hung, Adriana M.
    Grijalva, Carlos G.
    Greevy, Robert A.
    Liu, Xulei
    Elasy, Tom
    Roumie, Christianne L.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (06) : 638 - 646
  • [42] Effects of Mealtime Insulin Aspart and Bedtime NPH Insulin on Postprandial Inflammation and Endothelial Cell Function in Patients with Type 2 Diabetes
    Bladbjerg, Else-Marie
    Henriksen, Jan Erik
    Akram, Sumarra
    Gram, Jeppe
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (04) : 266 - 273
  • [43] Combination therapy for patients with Type 2 diabetes: repaglinide in combination with metformin
    Moses, Robert G.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (03) : 331 - 342
  • [44] Comparison of meal time insulin lispro (LP) versus bed-time NPH (NPH) after oral sulfonylurea (SU) failure
    Trautmann, M
    Johnson, M
    Anderson, JH
    Bastyr, EJ
    DIABETES, 1998, 47 : A91 - A91
  • [45] Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure
    Kokic, S
    Bukovic, D
    Radman, M
    Capkun, V
    Gabric, N
    Lesko, V
    Karelovic, D
    Stanceric, T
    COLLEGIUM ANTROPOLOGICUM, 2003, 27 (01) : 181 - 187
  • [46] Morning versus bedtime insulin glargine in combination with glimepiride: No difference in incidence of nocturnal hypoglycemia in patients with type 2 diabetes
    Standl, E
    Maxeiner, S
    Schweitzer, MA
    DIABETES, 2003, 52 : A134 - A134
  • [47] Factors influencing secondary sulfonylurea failure and insulin requirement in Korean type 2 diabetes mellitus
    Lee, H
    Moon, BS
    Joen, JS
    Han, KA
    Min, KW
    Kim, EJ
    DIABETES, 2003, 52 : A501 - A501
  • [48] ADDING INSULIN GLARGINE TO ORAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES RESULTS IN LONGER PERSISTENCE WITH TREATMENT COMPARED TO NPH INSULIN
    Pfohl, M.
    Dippel, F. W.
    Kostev, K.
    Kotowa, W.
    VALUE IN HEALTH, 2008, 11 (06) : A509 - A510
  • [49] Use of the combination of insulin and the prandial glucose regulator repaglinide in patients with Type 2 diabetes mellitus
    Davies, MJ
    Howe, J
    Jarvis, J
    Johnston, V
    Kitchener, D
    McNally, PG
    Lawrence, IG
    DIABETOLOGIA, 2002, 45 : A265 - A265
  • [50] EFFECT OF INSULIN GLARGINE OR NPH INSULIN ON TREATMENT SATISFACTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Moock, J.
    Hessel, F.
    Kohlmann, T.
    VALUE IN HEALTH, 2008, 11 (06) : A514 - A514
12345